000 03649nam a22003495i 4500
999 _c81696
_d81696
_x1
001 81696
003 ES-MaUEC
005 20230221040151.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 141027s2015 ne | s |||| 0|eng d
020 _a9789401794633
024 7 _a10.1007/978-94-017-9463-3
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQK495.L25
_b2015 EB
245 0 0 _aDan Shen (Salvia miltiorrhiza) in Medicine
_nVolume 2,
_pPharmacology and Quality Control
_cedited by Xijun Yan.
264 1 _aDordrecht, Netherlands
_bSpringer
_c2015
300 _a1 recurso en línea (XXXVI, 592 p.)
_b254 ilustraciones, 65 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aOverview of Modern Research on Danshen -- The Pharmacological Actions of Danshen ThemeD Formulas -- Active Constituents in Danshen and Their Pharmacological Actions -- Danshenâ€{u3825}ffects on the cardiovascular system -- Protective Effects of Danshen on Cerebral Vessels and the Nervous System -- Effect of Danshen on the Blood System and Microcirculatory Function -- Preventive and therapeutic effects of Danshen on digestive system diseases -- The Effects of Danshen on Respiratory Diseases and Their Mechanisms -- The Effects of Danshen on Kidney Diseases -- The Anti-tumor Effects of Danshen -- Studies on the Anti-bacterial and Anti-inflammatory -- Qualitative Research -- General Quality Control Methods -- Content Determination -- Fingerprint Study -- Quality Control of Dantonicâ{u282D}- In Vivo Metabolism of Danshen and its Preparations.
520 _aThis book reviews research on Dan Shen, compiles data from clinical trials and biological experiments, and summarizes the latest research advances. It covers the medicinal herb, herbal pieces, and new proprietary drugs that contain it; it also covers simple and compound, traditional and contemporary formulas, and addresses a broad range of subjects, including: standardized cultivation;Â{u08A9}odiversity; effective substances and their biological activities; quality control; and clinical trials. The book goes on to present the clinical trials on Dantonic, especially focusing on its therapeutic effects for coronary heart disease. It discusses compound prescriptions and compatibilities, from the herbal piece level to composition level, and describes approaches to research on modern Chinese medicine. Â{u05AF}lume 1 describes the biology and chemistry of Dan Shen, while Volume 2 focuses on pharmacology and quality control. Volume 3 describes the clinical research on Dan Shen. ÂŤitor Xijun Yan is the President of Tianjin Tasly Group and a Member of the TCM Standardization Technical Committee. Gathering contributions from more than 100 authors working in the field of pharmaceutical and clinical research, the book presents and analyzes the available information from multiple aspects, reflects the current status of Dan Shen research, and offers an essential reference work for further research and development.
988 _aEBOOK, EBSPRINGER
650 7 _aFarmacología
_2embne
_9137893
650 7 _aSalvias
_9671889
_2embne
700 1 _aYan, Xijun
_eeditor literario
_994275
_0Local
710 2 _aSpringerLink (Online service)
_0Local
_9106996
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-9463-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b11/2020
_dz
_eIG
_feng
_gne
_h0